A deep learning algorithm to predict coexisting metastatic disease using intraprostatic [F18]DCFPYL PSMA image alone in veterans with prostate cancer
Journal of Clinical Oncology Feb 28, 2020
Nickols NG, Anand A, Sjöstrand K, et al. - Given that [F18]DCFPyL (PyL) is a PSMA targeted imaging agent for prostate cancer, researchers sought to analyze the performance of a deep learning algorithm on PyL images of the primary tumor to anticipate co-existing distant metastases. Seventy-four veterans with high risk primary prostate cancer tumors were imaged with both PyL PSMA PET/CT and conventional imaging. According to findings, the logistical regression model using clinicopathologic features had an AUC of 0.71, whereas the PyL-AI model based on intra-prostatic PyL Images alone had an AUC of 0.81 for the anticipation of metastatic disease as defined by conventional imaging. Using classical clinicopathologic features, the PyL-AI deep learning model based on image demonstrates a higher predictive precision over the logistic model. The study is a hypothesis generating observation in an independent data set that needs prospective validation.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries